🔎 Trials Near Me

Home › Arrhythmia › NCT07772817

Feasibility and Usability of a Chest-Strap Ambulatory ECG Monitor in Active Individuals in Comparison With a Traditional Ambulatory ECG Patch Monitor (MoMe ARC)

RecruitingObservational study

Who can join

Ages 22 and older · All sexes

Full eligibility criteria
Inclusion Criteria:

* Adult participants (\>22 years; Frontier X is approved for use in this age group) who participate in \>4 days a week of \>150 minutes total per week of moderate to high intensity exercise who were prescribed a ambulatory ECG monitor for clinical purposes for 24 hours or more.
* Patients must agree to wear the Frontier X monitor for the prescribed duration and use the Frontier X Plus application

Exclusion Criteria:

* Current use of Implanted Cardiac Devices
* Pregnancy
* Known allergies to any of the materials listed in the "List of Patient-Contacting Materials"
* Presence of skin injuries or broken skin in the area where the chest strap is worn
* Inability to use a compatible mobile device required for the operation of the study device
* Any cognitive or physical limitations that, in the opinion of the investigator, limits the participant's ability to fully follow study procedures
* Medical restrictions on exercise for safety including cardiac, orthopedic or other relevant past medical history

About the study

The purpose of this research is to compare the standard ambulatory ECG monitor, the MoMe ARC, against Fourth Frontier's "Frontier X Plus". This device is an FDA-Cleared chest-strap-based ECG wearable that provides an alternative modality to capture ambulatory ECG rhythm changes.

What is being tested

Sponsor: Mayo Clinic · Participants: 15 · Started: 2026-09

Contact the study team

Official record on ClinicalTrials.gov — NCT07772817

Locations in the U.S.

ArizonaMayo Clinic Arizona, Scottsdale
FloridaMayo Clinic Florida, Jacksonville
MinnesotaMayo Clinic Rochester, Rochester

Conditions

From ClinicalTrials.gov, data retrieved Sep 29, 2026. Each study sets its own eligibility; the study team decides who can join.